BioLineRx Ltd. Quarterly Liabilities in USD from Q4 2016 to Q4 2024

Taxonomy & unit
ifrs-full: USD
Summary
BioLineRx Ltd. quarterly Liabilities history and growth rate from Q4 2016 to Q4 2024.
  • BioLineRx Ltd. Liabilities for the quarter ending December 31, 2024 was $25.4M, a 49.8% decline year-over-year.
Liabilities, Quarterly (USD)
Liabilities, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 $25.4M -$25.3M -49.8% Dec 31, 2024 20-F 2025-03-31
Q2 2024 $50.6M +$12.7M +33.6% Jun 30, 2024 6-K 2024-08-15
Q4 2023 $50.7M +$25.2M +98.5% Dec 31, 2023 20-F 2025-03-31
Q2 2023 $37.9M +$26.6M +236% Jun 30, 2023 6-K 2023-08-30
Q4 2022 $25.5M +$12.2M +92% Dec 31, 2022 20-F/A 2024-03-26
Q2 2022 $11.3M -$6.17M -35.4% Jun 30, 2022 6-K 2022-08-16
Q4 2021 $13.3M -$12M -47.3% Dec 31, 2021 20-F 2023-03-22
Q2 2021 $17.4M -$6.32M -26.6% Jun 30, 2021 6-K 2021-08-18
Q4 2020 $25.3M +$5.07M +25.1% Dec 31, 2020 20-F 2022-03-16
Q2 2020 $23.8M +$3.58M +17.8% Jun 30, 2020 6-K 2020-08-06
Q4 2019 $20.2M +$5.28M +35.4% Dec 31, 2019 20-F 2021-02-23
Q2 2019 $20.2M +$14.1M +235% Jun 30, 2019 6-K 2019-08-06
Q4 2018 $14.9M +$6.83M +84.5% Dec 31, 2018 20-F 2020-03-12
Q2 2018 $6.03M Jun 30, 2018 6-K 2018-08-13
Q4 2017 $8.08M +$4.17M +107% Dec 31, 2017 20-F 2019-03-28
Q4 2016 $3.91M Dec 31, 2016 20-F 2018-03-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.